Cutting off cancer cells' access to fat may help a specific type of cancer treatment work more effectively, reports a study ...

Colistin is a last-resort antibiotic that is usually only used for severe infections with resistant bacteria. This is due to its severe kidney-damaging side effects, which occur in about 30% of ...

For some proteins, a single mutation, or change in its DNA instructions, is all it takes to tip the balance between ...

Researchers at NYU Langone Health developed a new drug that targets mutant HER2 cancer proteins without harming healthy cells ...

Scientists at NYU have created a drug that targets cancer-causing HER2 mutations without harming healthy cells. This new ...

According to a study conducted by researchers at the Van Andel Institute, preventing cancer cells from obtaining fat may ...

A new study describes the development of a biologic, a drug derived from natural biological systems, that targets a mutant cancer protein called HER2 (human epidermal growth factor receptor 2) without ...

Researchers from Nagoya University Institute of Transformative Biomolecules (WPI-ITbM) in Japan and their colleagues have ...

Antibodies show promise as candidates for therapeutics as well as tools for advancing mechanistic studies of the HER family receptors.

Rensselaer Polytechnic Institute (RPI) has been awarded two grants by the National Institute on Aging (NIA) to train graduate ...